A Pilot Trial of Stepwise Implementation of Virtual Reality Mindfulness and Accelerated Transcranial Magnetic Stimulation Treatments for Dysphoria in Neuropsychiatric Disorders

Table 6

Paired -tests of primary clinician and self-rated scales from VR visit 1 to the designated VR endpoint within diagnostic groups.

Measure	Mean		Std. error mean difference	Mean difference			Sig. (2-tailed)
	VR visit 1	VR endpoint
Depression
PHQ-9	17.25	15.31	.6156	1.938	3.148	15	.007
MADRS	31.25	29.00	1.4986	2.2500	1.501	15	.154
Anxiety
GAD-7	15.33	13.93	.8826	1.4000	1.586	14	.135
HAM-A	26.13	23.33	1.3565	2.8000	2.064	14	.058
PTSD
PCL-5	56.62	47.00	2.5977	9.6250	3.705	7	.008
CAPS-5	50.25	46.50	2.2019	3.7500	1.703	7	.132
Chronic pain
PROMIS pain intensity	5.87	6.07	.3409	-.2000	-.587	14	.567
PROMIS pain interference	14.73	13.80	.9333	.9333	1.000	14	.334